{"id":"clindamycin-gel-clindamycin","safety":{"commonSideEffects":[{"rate":null,"effect":"Dryness or peeling at application site"},{"rate":null,"effect":"Erythema or irritation at application site"},{"rate":null,"effect":"Oiliness or greasiness"},{"rate":null,"effect":"Folliculitis"}]},"_chembl":null,"_dailymed":{"setId":"6df9e011-3959-411d-9e28-1df097829028","title":"CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE (CLINDAMYCIN AND BENZOYL PEROXIDE GEL) KIT [SUN PHARMACEUTICAL INDUSTRIES, INC.]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Clindamycin binds to the bacterial 50S ribosomal subunit and inhibits peptide bond formation, preventing bacterial protein synthesis. This bacteriostatic action is effective against a broad range of gram-positive and anaerobic bacteria. When formulated as a topical gel, it is particularly useful for treating acne by reducing Cutibacterium acnes (formerly Propionibacterium acnes) colonization on the skin.","oneSentence":"Clindamycin is a lincosamide antibiotic that inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:06:19.158Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Acne vulgaris (topical)"},{"name":"Bacterial skin infections (topical)"}]},"trialDetails":[{"nctId":"NCT07421804","phase":"NA","title":"Evaluation of Topical Dutasteride as a Potential New Therapy for Facial Acne Vulgaris Versus the Triple Combination Therapy (Clindamycin Phosphate 1.2%, Benzoyl Peroxide 3.1%, and Adapalene 0.15% Gel)","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2026-04","conditions":"Acne Vulgaris","enrollment":50},{"nctId":"NCT07392047","phase":"PHASE4","title":"Metronidazole 2% Gel Versus Clindamycin 1% Gel for Moderate Acne Vulgaris","status":"NOT_YET_RECRUITING","sponsor":"Jinnah Postgraduate Medical Centre","startDate":"2026-02","conditions":"Acne Vulgaris","enrollment":60},{"nctId":"NCT07205107","phase":"","title":"Clindamycin Phosphate, Adapalene, and Benzoyl Peroxide Triple Combination Gel in Canadian Patients With Acne Vulgaris","status":"RECRUITING","sponsor":"Bausch Health Americas, Inc.","startDate":"2025-10-02","conditions":"Acne Vulgaris","enrollment":200},{"nctId":"NCT05582434","phase":"EARLY_PHASE1","title":"Experience With Topical Acne Treatment","status":"ACTIVE_NOT_RECRUITING","sponsor":"Wake Forest University Health Sciences","startDate":"2024-02-15","conditions":"Acne","enrollment":72},{"nctId":"NCT02779179","phase":"NA","title":"Therapeutic Management of Periodontitis and Clinical Manifestations of Rheumatoid Arthritis","status":"COMPLETED","sponsor":"University Hospital, Toulouse","startDate":"2010-11","conditions":"Periodontitis, Rheumatoid Arthritis","enrollment":22},{"nctId":"NCT04892706","phase":"PHASE2","title":"Study to Compare the Safety and Efficacy of IDP-126 Gel to Epiduo® Forte Gel and Vehicle Gel","status":"COMPLETED","sponsor":"Bausch Health Americas, Inc.","startDate":"2021-06-11","conditions":"Acne Vulgaris","enrollment":686},{"nctId":"NCT07123792","phase":"NA","title":"Effect of Intracanal Medicaments on Post-Operative Pain in Symptomatic Apical Periodontitis: An RCT","status":"COMPLETED","sponsor":"HITEC-Institute of Medical Sciences","startDate":"2024-06-03","conditions":"Periodontal Diseases","enrollment":480},{"nctId":"NCT04469075","phase":"PHASE2","title":"Clindamycin and Triamcinolone in People With Glioblastoma to Prevent Skin-Related Side Effects of Tumor Treating Fields","status":"ACTIVE_NOT_RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2020-07-09","conditions":"Glioblastoma, Recurrent Glioblastoma, Skin Toxicity","enrollment":48},{"nctId":"NCT06336629","phase":"PHASE4","title":"A Study Assessing the Efficacy and Safety of Combined Use of Clascoterone 1% Cream and Duac Gel (Benzoyl Peroxide/Clindamycin) for the Treatment of Acne","status":"COMPLETED","sponsor":"Sun Pharmaceutical Industries Limited","startDate":"2023-11-15","conditions":"Acne Vulgaris","enrollment":10},{"nctId":"NCT06673641","phase":"PHASE1","title":"A Study Comparing Clindamycin Phosphate, Adapalene, and Benzoyl Peroxide Topical Gel 0.15%;3.1%;1.2% (Taro Pharmaceuticals U.S.A., Inc.) and CABTREO Topical Gel for the Treatment of Acne Vulgaris.","status":"COMPLETED","sponsor":"Sun Pharmaceutical Industries, Inc.","startDate":"2024-05-13","conditions":"Acne Vulgaris","enrollment":382},{"nctId":"NCT06175819","phase":"NA","title":"Efficacy of Manuka Honey Nano-Formulation in the Treatment of Acne Vulgaris","status":"UNKNOWN","sponsor":"Al-Azhar University","startDate":"2024-01","conditions":"Acne Vulgaris","enrollment":102},{"nctId":"NCT01044264","phase":"NA","title":"Clinical Study Between Two 1% Clindamycin/5% Benzoyl Peroxide Topical Gel Formulations","status":"COMPLETED","sponsor":"Padagis LLC","startDate":"2007-12","conditions":"Acne Vulgaris","enrollment":602},{"nctId":"NCT05926869","phase":"PHASE2","title":"Comparison of the Efficacy of Clindamycin Phosphate 1% Gel Versus Once-daily Dapsone 5% Gel in the Treatment of Moderate Acne Vulgaris","status":"COMPLETED","sponsor":"Jinnah Postgraduate Medical Centre","startDate":"2022-08-01","conditions":"Acne Vulgaris","enrollment":100},{"nctId":"NCT05465304","phase":"","title":"Effect of Azithromycin in Preventing Premature Labour","status":"COMPLETED","sponsor":"Beni-Suef University","startDate":"2021-10-01","conditions":"Pregnant With Complication","enrollment":200},{"nctId":"NCT03849885","phase":"PHASE4","title":"Cutibacterium Dermal Colonization: Implications for Total Hip Arthroplasty","status":"UNKNOWN","sponsor":"Colorado Joint Replacement","startDate":"2019-02-02","conditions":"Degenerative Osteoarthritis","enrollment":496},{"nctId":"NCT04370548","phase":"PHASE3","title":"DARE-BV1 in the Treatment of Bacterial Vaginosis (DARE-BVFREE)","status":"COMPLETED","sponsor":"Daré Bioscience, Inc.","startDate":"2020-06-16","conditions":"Bacterial Vaginosis","enrollment":307},{"nctId":"NCT01874860","phase":"PHASE2","title":"Skin Rash Study Before Chemotherapy in Colorectal & Head and Neck Cancer Patients","status":"COMPLETED","sponsor":"University of Louisville","startDate":"2013-08","conditions":"Colorectal Cancer, Head and Neck Cancer","enrollment":24},{"nctId":"NCT00671749","phase":"PHASE4","title":"Combination Therapy With Differin® Gel 0.3% and Duac® (Clindamycin/Benzoyl Peroxide Gel) in Subjects With Acne Vulgaris","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2007-12","conditions":"Acne Vulgaris","enrollment":100},{"nctId":"NCT02515305","phase":"PHASE3","title":"Comparative Safety and Efficacy of Two Treatments in the Treatment of Acne Vulgaris","status":"COMPLETED","sponsor":"Padagis LLC","startDate":"2015-07","conditions":"Acne","enrollment":890},{"nctId":"NCT01796665","phase":"PHASE3","title":"A Study to Compare Clindamycin Phosphate and Benzoyl Peroxide Topical Gel 1.2%/2.5% to Acanya® Topical Gel in the Treatment of Acne Vulgaris","status":"COMPLETED","sponsor":"Padagis LLC","startDate":"2012-02","conditions":"Acne","enrollment":1180},{"nctId":"NCT01138514","phase":"PHASE3","title":"Clinical Study Between Two Clindamycin 1%/Benzoyl Peroxide 5% Topical Gels","status":"COMPLETED","sponsor":"Padagis LLC","startDate":"2009-10","conditions":"Acne Vulgaris","enrollment":1555},{"nctId":"NCT03779360","phase":"NA","title":"Intradermal LPS and Antibiotics","status":"COMPLETED","sponsor":"Centre for Human Drug Research, Netherlands","startDate":"2018-10-12","conditions":"Inflammation; Skin","enrollment":32},{"nctId":"NCT00441415","phase":"PHASE3","title":"Efficacy and Safety of Fixed Combination Adapalene 0.1% / Benzoyl Peroxide 2.5% Gel in the Treatment of Acne Vulgaris","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2007-02","conditions":"Acne Vulgaris","enrollment":272},{"nctId":"NCT04584840","phase":"NA","title":"Initial Management of MRONJ Stages I and II, a Clinical Trial With Detection of Salivary Biomarkers","status":"UNKNOWN","sponsor":"Fundació d'investigació Sanitària de les Illes Balears","startDate":"2020-11-01","conditions":"Osteonecrosis of the Jaw, Bisphosphonate Induced, Osteonecrosis of the Jaw, Bisphosphonate Related","enrollment":50},{"nctId":"NCT02005666","phase":"PHASE3","title":"To Compare the Efficacy and Safety of Clindamycin Phosphate 1.2% / Benzoyl Peroxide 5% Gel of CHL Versus DUAC® Gel","status":"COMPLETED","sponsor":"Zydus Lifesciences Limited","startDate":"2013-11","conditions":"Acne Vulgaris","enrollment":850},{"nctId":"NCT03522441","phase":"PHASE3","title":"Bioequivalence Study of Clindamycin Gel 1% in Treatment of Acne Vulgaris","status":"COMPLETED","sponsor":"Akorn, Inc.","startDate":"2018-04-27","conditions":"Acne Vulgaris","enrollment":1125},{"nctId":"NCT03122457","phase":"PHASE2","title":"Perimenstrual Acne With Clindamycin Phosphate and Benzoyl Peroxide","status":"COMPLETED","sponsor":"Icahn School of Medicine at Mount Sinai","startDate":"2017-01-01","conditions":"Actinic Keratosis","enrollment":22},{"nctId":"NCT02616614","phase":"PHASE3","title":"Double-blind Placebo-controlled Trial of Generic Clindamycin/Benzoyl Peroxide Gel Versus Onexton Gel in Acne Vulgaris","status":"COMPLETED","sponsor":"Actavis Inc.","startDate":"2015-05","conditions":"Acne Vulgaris","enrollment":862},{"nctId":"NCT03615768","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of Adapalene-Clindamycin Combination Gel in the Treatment of Acne Vulgaris","status":"COMPLETED","sponsor":"Lee's Pharmaceutical Limited","startDate":"2018-08-14","conditions":"Acne Vulgaris","enrollment":1617},{"nctId":"NCT03257202","phase":"PHASE2","title":"Topical Treatment and Prevalence of P. Acnes","status":"COMPLETED","sponsor":"University of Southern California","startDate":"2017-09-11","conditions":"Surgical Site Infection","enrollment":12},{"nctId":"NCT04134273","phase":"PHASE1","title":"Bio-equivalence Study With Clinical Endpoints in the Treatment of Acne Vulgaris","status":"COMPLETED","sponsor":"Sun Pharmaceutical Industries, Inc.","startDate":"2019-03-20","conditions":"Acne Vulgaris","enrollment":1260},{"nctId":"NCT02593383","phase":"PHASE1, PHASE2","title":"Compound Adapalene and Clindamycin Hydrochloride Gel in Treatment of Patients With Acne","status":"COMPLETED","sponsor":"Lee's Pharmaceutical Limited","startDate":"2015-03-01","conditions":"Acne","enrollment":245},{"nctId":"NCT03883269","phase":"PHASE4","title":"Anti-inflammatory Effects of Topical Erythromycin and Clindamycin in Acne Patients","status":"RECRUITING","sponsor":"Centre for Human Drug Research, Netherlands","startDate":"2018-03-20","conditions":"Acne Vulgaris","enrollment":30},{"nctId":"NCT02731105","phase":"PHASE4","title":"Pilot Study of Tolerability and Effectivity of Two Combination Topical Acne Products","status":"COMPLETED","sponsor":"GWT-TUD GmbH","startDate":"2015-02","conditions":"Acne Vulgaris","enrollment":22},{"nctId":"NCT01047189","phase":"PHASE4","title":"Adherence to Study Medication Compared to Generic Topical Clindamycin Plus Generic Topical Tretinoin in Subjects With Mild to Moderate Acne Vulgaris","status":"COMPLETED","sponsor":"Wake Forest University","startDate":"2009-03","conditions":"Acne Vulgaris","enrollment":26},{"nctId":"NCT02557399","phase":"PHASE4","title":"DUAC® Early Onset Efficacy Study in Japanese Subjects","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2015-10-07","conditions":"Acne Vulgaris","enrollment":350},{"nctId":"NCT02578043","phase":"PHASE1","title":"A Study Comparing Clindamycin and Benzoyl Peroxide Gel 1.2%/3.75% to Onexton™ Gel in the Treatment of Acne Vulgaris","status":"COMPLETED","sponsor":"Sun Pharmaceutical Industries, Inc.","startDate":"2015-04","conditions":"Acne Vulgaris","enrollment":844},{"nctId":"NCT01445301","phase":"PHASE3","title":"Study STF115287, a Clinical Confirmation Study of GSK2585823 in the Treatment of Acne Vulgaris in Japanese Subjects","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2011-09-27","conditions":"Acne Vulgaris","enrollment":800},{"nctId":"NCT02058628","phase":"PHASE4","title":"Comparison of the Efficacy and Safety of Clindamycin + Benzoyl Peroxide Formulation With Azelaic Acid Formulation in the Treatment of Acne Vulgaris","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2014-02-21","conditions":"Acne Vulgaris","enrollment":222},{"nctId":"NCT00757523","phase":"PHASE4","title":"Evaluation of the Effectiveness, Safety, and Tolerability of Duac Akne Gel and Epiduo Gel in the Treatment of Facial Acne Vulgaris","status":"COMPLETED","sponsor":"Stiefel, a GSK Company","startDate":"2008-09-10","conditions":"Acne Vulgaris","enrollment":382},{"nctId":"NCT01428466","phase":"PHASE1","title":"Japanese Phase 1 Study of GSK2585823","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2010-11-18","conditions":"Acne Vulgaris","enrollment":20},{"nctId":"NCT01929278","phase":"PHASE1","title":"W0265-103: A Single-Center, Evaluator-Blinded, Randomized, Placebo Controlled, Phase 1 Clinical Trial Evaluating The Phototoxic Potential Of Topically Applied Clindamycin 1.0% - Tretinoin 0.025% Gel (Ct Gel) In Healthy Volunteers","status":"COMPLETED","sponsor":"Stiefel, a GSK Company","startDate":"2008-12-08","conditions":"Acne Vulgaris","enrollment":37},{"nctId":"NCT01915758","phase":"PHASE1","title":"W0265-104: A Single-Center, Evaluator-Blinded, Randomized, Placebo-Controlled, Phase 1 Clinical Trial Evaluating the Photoallergic Potential of Topically Applied Clindamycin Phosphate 1.0% and Tretinoin 0.025% (CT Gel) in Healthy Volunteers","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2008-11-21","conditions":"Acne Vulgaris","enrollment":64},{"nctId":"NCT02465632","phase":"PHASE3","title":"To Study Generic Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel (Glenmark Generics, Ltd) in the Treatment of Acne Vulgaris.","status":"COMPLETED","sponsor":"Glenmark Pharmaceuticals Ltd. India","startDate":"2015-04","conditions":"Acne Vulgaris","enrollment":1100},{"nctId":"NCT01132443","phase":"PHASE1","title":"W0261-101: A Phase 1, Single Center, Randomized, Open-Label Study to Evaluate the Bioavailability of Clindamycin From Clindamycin 1%-Benzoyl Peroxide 3% Gel, Topical Gel (Clindamycin 1%- Benzoyl Peroxide 5%), and Once Daily Gel (Clindamycin 1%-Benzoyl Peroxide 5%) in Subjects With Acne","status":"COMPLETED","sponsor":"Stiefel, a GSK Company","startDate":"2010-05-06","conditions":"Acne Vulgaris","enrollment":72},{"nctId":"NCT00964366","phase":"PHASE4","title":"Study to Determine and Compare the Tolerance and Irritation Potential of Topical Acne Medications","status":"COMPLETED","sponsor":"Stiefel, a GSK Company","startDate":"2009-07","conditions":"Acne Vulgaris","enrollment":53},{"nctId":"NCT00689117","phase":"PHASE3","title":"A Clinical Study to Evaluate the Safety and Effectiveness of an Investigational Product Called CT Gel","status":"COMPLETED","sponsor":"Stiefel, a GSK Company","startDate":"2008-04","conditions":"Acne Vulgaris, Acne","enrollment":1649},{"nctId":"NCT00841776","phase":"PHASE4","title":"Comparative Antimicrobial Efficacy of Two Topical Acne Therapies for the Treatment of Facial Acne","status":"COMPLETED","sponsor":"Stiefel, a GSK Company","startDate":"2007-08","conditions":"Acne","enrollment":54},{"nctId":"NCT00891982","phase":"PHASE3","title":"A Clinical Study to Evaluate the Tolerability of a Topical Antibiotic and Retinoid Used in a Combined Regimen With a BPO Wash","status":"COMPLETED","sponsor":"Stiefel, a GSK Company","startDate":"2009-04-01","conditions":"Acne Vulgaris","enrollment":60},{"nctId":"NCT01769235","phase":"PHASE1","title":"Study Comparing Clindamycin Phosphate and Benzoyl Peroxide Gel to Acanya® Gel and Both to a Vehicle Control in the Treatment of Acne Vulgaris","status":"COMPLETED","sponsor":"Sun Pharmaceutical Industries, Inc.","startDate":"2012-11","conditions":"Acne Vulgaris","enrollment":1215},{"nctId":"NCT02595034","phase":"PHASE1","title":"A Study CLBG and Benzoyl Peroxide Gel 1%/5% to BenzaClin® Gel in the Treatment of Acne Vulgaris","status":"COMPLETED","sponsor":"Sun Pharmaceutical Industries, Inc.","startDate":"2015-01","conditions":"Acne Vulgaris","enrollment":1000},{"nctId":"NCT01015638","phase":"PHASE4","title":"Compare the Tolerance of Clindamycin 1% /Benzoyl Peroxide (BPO) 5% Gel to Clindamycin 1.2%/ BPO 2.5% Topical Medications","status":"COMPLETED","sponsor":"Stiefel, a GSK Company","startDate":"2009-08","conditions":"Acne Vulgaris","enrollment":36},{"nctId":"NCT00713609","phase":"PHASE2","title":"Safety and Efficacy Study of Clindamycin/Benzoyl Peroxide/Tazarotene Cream in Subjects With Acne","status":"COMPLETED","sponsor":"Stiefel, a GSK Company","startDate":"2008-06","conditions":"Acne Vulgaris","enrollment":591},{"nctId":"NCT01915732","phase":"PHASE3","title":"A Efficacy and Safety of Duac™Compared With Clindamycin Phosphate Gel in the Treatment of Mild to Moderate Acne Vulgaris","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2013-04","conditions":"Acne Vulgaris","enrollment":1018},{"nctId":"NCT01016977","phase":"PHASE4","title":"A Phase 4, Single-Blind, Randomized, Study to Compare the Tolerability and Efficacy of 0.1% Tazorac Cream When Used in Combination With Either Duac Gel or Acanya Gel for the Treatment of Facial Acne Vulgaris","status":"COMPLETED","sponsor":"Stiefel, a GSK Company","startDate":"2009-10","conditions":"Acne Vulgaris","enrollment":40},{"nctId":"NCT02721173","phase":"PHASE4","title":"Tazarotene Plus Clindamycin vs. Adapalene Plus Clindamycin in the Treatment of Facial Acne Vulgaris","status":"COMPLETED","sponsor":"All India Institute of Medical Sciences, Bhubaneswar","startDate":"2016-04","conditions":"Acne Vulgaris","enrollment":60},{"nctId":"NCT00887484","phase":"PHASE4","title":"A Comparative Study of the Tolerability of Two Combination Therapies for the Treatment of Acne","status":"COMPLETED","sponsor":"Stiefel, a GSK Company","startDate":"2009-02","conditions":"Acne Vulgaris","enrollment":50},{"nctId":"NCT00964223","phase":"PHASE4","title":"A Study to Evaluate Tolerability of Two Topical Drug Products in the Treatment of Facial Acne","status":"COMPLETED","sponsor":"Stiefel, a GSK Company","startDate":"2009-07","conditions":"Acne Vulgaris","enrollment":28},{"nctId":"NCT00776919","phase":"PHASE3","title":"Trial of Clindamycin / Benzoyl Peroxide Gel in Subjects With Acne","status":"COMPLETED","sponsor":"Stiefel, a GSK Company","startDate":"2008-10","conditions":"Acne Vulgaris","enrollment":1315},{"nctId":"NCT00926367","phase":"PHASE4","title":"Two-week Study to Compare the Tolerance and Irritation Potential of Two Combination Topical Gel Acne Medications","status":"COMPLETED","sponsor":"Stiefel, a GSK Company","startDate":"2009-05","conditions":"Acne Vulgaris","enrollment":52},{"nctId":"NCT01400932","phase":"PHASE3","title":"Study STF115288, a Clinical Confirmation Study of GI148512 in the Treatment of Acne Vulgaris in Japanese Subjects","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2011-07","conditions":"Acne Vulgaris","enrollment":360},{"nctId":"NCT01769664","phase":"PHASE1","title":"A Study Comparing Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel to Duac® Topical Gel in the Treatment of Acne Vulgaris","status":"COMPLETED","sponsor":"Sun Pharmaceutical Industries, Inc.","startDate":"2012-09","conditions":"Acne Vulgaris","enrollment":650},{"nctId":"NCT01788384","phase":"PHASE3","title":"Evaluate Therapeutic Equivalence and Safety of Two Clindamycin Phosphate and Benzoyl Peroxide Gels in Acne Vulgaris","status":"COMPLETED","sponsor":"Watson Laboratories, Inc.","startDate":"2012-07","conditions":"Acne Vulgaris","enrollment":708},{"nctId":"NCT01231334","phase":"PHASE4","title":"A Study Comparing Aczone® Plus Differin® Versus Duac® Plus Differin® in Patients With Severe Facial Acne","status":"COMPLETED","sponsor":"Allergan","startDate":"2010-08","conditions":"Acne Vulgaris","enrollment":286},{"nctId":"NCT00823901","phase":"PHASE2, PHASE3","title":"Safety and Efficacy Study of Clindamycin Phosphate 1.2% and Tretinoin 0.025% Gel to Treat Rosacea","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2009-02","conditions":"Rosacea","enrollment":83},{"nctId":"NCT01472900","phase":"NA","title":"2940nm Er:YAG Laser Versus Benzoyl Peroxide Gel for the Treatment of Inflammatory Acne","status":"COMPLETED","sponsor":"Chulalongkorn University","startDate":"2010-10","conditions":"Acne Vulgaris","enrollment":25},{"nctId":"NCT00807014","phase":"PHASE4","title":"Evaluation of Quality of Life, Efficacy, and Tolerance of Duac® Gel Compared to Differin® Gel in the Treatment of Acne","status":"COMPLETED","sponsor":"Stiefel, a GSK Company","startDate":"2006-11","conditions":"Acne Vulgaris","enrollment":169},{"nctId":"NCT01206348","phase":"PHASE4","title":"Combination Treatment for Moderate to Severe Acne","status":"COMPLETED","sponsor":"Medicis Global Service Corporation","startDate":"2010-09","conditions":"Acne","enrollment":97},{"nctId":"NCT01448733","phase":"PHASE4","title":"Safety and Tolerability of Acanya Gel in Combination With Atralin Gel for Acne Vulgaris","status":"UNKNOWN","sponsor":"Zeichner, Joshua, M.D.","startDate":"2011-07","conditions":"Acne Vulgaris","enrollment":20},{"nctId":"NCT01422785","phase":"PHASE4","title":"A Study Comparing Combination Clindamycin Phosphate/Tretinoin Gel Alone Versus With Benzoyl Peroxide Foaming Cloths for Facial Acne","status":"UNKNOWN","sponsor":"Zeichner, Joshua, M.D.","startDate":"2011-07","conditions":"Acne Vulgaris","enrollment":40},{"nctId":"NCT00219570","phase":"PHASE4","title":"Dalacin-T Gel Post Approval Study","status":"COMPLETED","sponsor":"Pfizer","startDate":"2005-01","conditions":"Acne Vulgaris","enrollment":134},{"nctId":"NCT01257906","phase":"NA","title":"Bioequivalence Study Comparing Clindamycin Phosphate (1.2%) and Tretinoin (0.025%) Topical Gel to Ziana and Placebo","status":"COMPLETED","sponsor":"Actavis Mid-Atlantic LLC","startDate":"2010-05","conditions":"MILD TO SEVERE ACNE VULGARIS","enrollment":1225},{"nctId":"NCT00838812","phase":"PHASE3","title":"Safety and Efficacy Study of Association Between Tretinoin and Clindamycin on the Treatment of Acne Mild and Moderate","status":"COMPLETED","sponsor":"Igefarma Laboratorios S.A.","startDate":"2009-03","conditions":"Acne Vulgaris","enrollment":154},{"nctId":"NCT01111994","phase":"PHASE4","title":"Efficacy & Safety of Clindamycin and Tretinoin in Acne","status":"UNKNOWN","sponsor":"Callender Center for Clinical Research","startDate":"2009-11","conditions":"Acne","enrollment":30},{"nctId":"NCT01052246","phase":"NA","title":"Pulsed Dye Laser Treatment of Acne Vulgaris","status":"COMPLETED","sponsor":"Laserklinik Karlsruhe","startDate":"2008-10","conditions":"Acne Vulgaris","enrollment":80},{"nctId":"NCT00377000","phase":"PHASE4","title":"A Pilot, Multi-Center, Patient Preference Study Comparing Two Clindamycin/Benzoyl Peroxide Gels.","status":"COMPLETED","sponsor":"Sanofi","startDate":"2005-11","conditions":"Acne Vulgaris","enrollment":60}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Clindamycin Gel (clindamycin )","genericName":"Clindamycin Gel (clindamycin )","companyName":"Stiefel, a GSK Company","companyId":"stiefel-a-gsk-company","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Clindamycin is a lincosamide antibiotic that inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit. Used for Acne vulgaris (topical), Bacterial skin infections (topical).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}